Detalhe da pesquisa
1.
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses.
Mol Ther
; 24(1): 166-74, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26310630
2.
Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus.
Mol Ther
; 22(10): 1851-63, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24957982
3.
The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical site.
Mol Ther
; 22(11): 1936-48, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25059678
4.
The efficacy versus toxicity profile of combination virotherapy and TLR immunotherapy highlights the danger of administering TLR agonists to oncolytic virus-treated mice.
Mol Ther
; 21(2): 348-57, 2013 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23011032
5.
Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse.
Mol Ther
; 21(8): 1507-16, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23752316
6.
Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma.
Mol Ther
; 20(10): 1998-2003, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22871663
7.
Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic viruses.
Mol Ther Oncolytics
; 29: 129-142, 2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37313455
8.
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.
Front Immunol
; 14: 1279387, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38022659
9.
Adoptive T cell therapy promotes the emergence of genomically altered tumor escape variants.
Int J Cancer
; 131(4): 844-54, 2012 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21935923
10.
Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells.
Nat Med
; 11(10): 1073-81, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16170322
11.
VSV oncolytic virotherapy in the B16 model depends upon intact MyD88 signaling.
Mol Ther
; 19(1): 150-8, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20959810
12.
Vesicular stomatitis virus-induced immune suppressor cells generate antagonism between intratumoral oncolytic virus and cyclophosphamide.
Mol Ther
; 19(1): 140-9, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20978474
13.
Precise scheduling of chemotherapy primes VEGF-producing tumors for successful systemic oncolytic virotherapy.
Mol Ther
; 19(10): 1802-12, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21792179
14.
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer.
BMC Cancer
; 11: 221, 2011 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21645351
15.
Inactivation of Replication-Competent Vesicular Stomatitis Virus as SARS-CoV-2 Surrogate on Common Surfaces by Disinfectants.
Int J Environ Res Public Health
; 18(14)2021 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34300163
16.
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy.
Nat Commun
; 12(1): 1930, 2021 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33772027
17.
Improved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2.
Clin Cancer Res
; 15(2): 561-9, 2009 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19147761
18.
Cell carriers for oncolytic viruses: Fed Ex for cancer therapy.
Mol Ther
; 17(10): 1667-76, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19690519
19.
Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors.
Neuro Oncol
; 22(12): 1757-1770, 2020 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32459315
20.
APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy.
Nat Commun
; 11(1): 790, 2020 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32034147